HealthEquity (HQY) free cash flow

Free cash flow · fiscal 2026
$408.32M

HealthEquity (HQY) generated free cash flow of $408.32M in fiscal 2026 (the year ended January 31, 2026). In fiscal 2025 the figure was -$165.60M. Figures as of 18 Nov 2026, 12:42 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2026
$408.32M
Growth, 5 years
+19.4% a year
Growth, 10 years
+32.7% a year
Highest on record
$408.32Mfiscal 2026
Lowest on record
-$165.60Mfiscal 2025
Fiscal years on record
142013–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

HealthEquity free cash flow, in more detail

Over the five fiscal years to 2026 free cash flow grew at a compound 19.4% a year; over ten years the rate was 32.7% a year. Across the 14 fiscal years on record (2013–2026), the highest was $408.32M in fiscal 2026 and the lowest -$165.60M in fiscal 2025.

History · 14 fiscal years

Free cash flow by fiscal year

HealthEquity free cash flow, year by year

HealthEquity (HQY) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2026$408.32M—
2025-$165.60M 184.2% down
2024$196.75M 524.2% up
2023$31.52M 76.1% down
2022$132.09M 21.6% down
2021$168.53M 72.5% up
2020$97.72M 10.8% down
2019$109.55M 43.7% up
2018$76.24M 81.8% up
2017$41.95M 73.6% up
2016$24.17M 81.2% up
2015$13.33M 18.8% down
2014$16.42M 50.1% up
2013$10.94M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of HealthEquity and comparable companies
CompanyFree cash flowFiscal year
Twist Bioscience TWST-$95.96M2026
Protagonist Therapeutics PTGX$56.08M2025
Krystal Biotech KRYS$188.91M2025
10x Genomics TXG$130.12M2025
HealthEquity HQY$408.32M2026
Corcept Therapeutics CORT$141.79M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HQY

HealthEquity, figure by figure

HealthEquity (HQY) overview: price, valuation and scorecardAll health care companies by market value

HealthEquity free cash flow: questions and answers

What is HealthEquity's free cash flow?

HealthEquity (HQY) generated free cash flow of $408.32M in fiscal 2026 (the year ended January 31, 2026). In fiscal 2025 the figure was -$165.60M.

What is the growth rate of HealthEquity's free cash flow?

Over the five fiscal years to 2026 free cash flow grew at a compound 19.4% a year; over ten years the rate was 32.7% a year.

What are the highest and lowest free cash flow figures on record for HealthEquity?

Across the 14 fiscal years on record (2013–2026), the highest was $408.32M in fiscal 2026 and the lowest -$165.60M in fiscal 2025.

How is HealthEquity's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For HealthEquity it is on record here for 14 fiscal years, 2013 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “HealthEquity (HQY) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/HQY/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.